MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3626-3634

  Turnbull, Peter C B ^a,b   Sirianni, Nicky M ^a,c   LeBron, Carlos I ^a   Samaan, Marian N ^a   Sutton, Felicia N ^a   Reyes, Anatalio E ^a   Peruski Jr , Leonard F ^a,d  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b NMRC   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE NORTHWEST   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS MYCOIDES; BACILLUS THURINGIENSIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; ENVIRONMENT; FOOD POISONING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS THURINGIENSIS; FOOD POISONING; HUMANS; MICROBIAL SENSITIVITY TESTS;

BACILLUS ANTHRACIS; BACILLUS CEREUS; BACILLUS MYCOIDES; BACILLUS THURINGIENSIS; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 3843052532     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3626-3634.2004     Document Type: Article

References (43)

1. Andrews, J. M., and R. Wise. 2002. Susceptibility testing of Bacillus species. J. Antimicrob. Chemother. 49:1040-1042.
2. Anonymous. 1996. Bits and pieces (from poster boards at the workshop): references to penicillin resistance. Proceedings of the International Workshop on Anthrax, 19-21 September 1995, Winchester, England. Salisbury Med. Bull. 87(Suppl.):139.
3. Auerbach, S., and G. G. Wright. 1955. Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis. J. Immunol. 75:129-133.
4. Barnes, J. M. 1947. Penicillin and B. anthracis. J. Pathol. Bacteriol. 59:113-125.
5. Breathnach, A. S., P. C. Turnbull, S. J. Eykyn, and C. H. Twort. 1996. A labourer with a spot on his chest. Lancet 347:96.
6. Cavallo, J.-D., F. Ramisse, M. Giradet, J. Vaissaire, M. Mock, and E. Hernandez. 2002. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Antimicrob. Agents Chemother. 46:2307-2309.
7. Centers for Disease Control and Prevention. 2001. Notice to readers: update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. Morb. Mortal. Wkly. Rep. 50-1014-1016.
8. Centers for Disease Control and Prevention. 2001. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Morb. Mortal. Wkly. Rep. 50:909-919.
9. Chen, Y., J. Succi, F. C. Tenover, and T. M. Koehler. 2003. β-Lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 185:823-830.
10. Choe, C. H., S. S. Bouhaouala, I. Brook, T. B. Elliott, and G. B. Knudson. 2000. In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob. Agents Chemother. 44:1766.
11. Coker, P. R., K. L. Smith, and M. E. Hugh-Jones. 2002. Antimicrobial susceptibilities of diverse Bacillus anthracis isolates. Antimicrob. Agents Chemother. 46:3843-3845.
12. Cowles, P. B. 1931. A bacteriophage for B. anthracis. 21:161-166.
13. Doganay, M., and N. Aydin. 1991. Antimicrobial susceptibility of Bacillus anthracis. Scand. J. Infect. Dis. 23:333-335.
14. Drobniewski, F. A. 1993. Bacillus cereus and related species. Clin. Microbiol. Rev. 6:324-338.
15. Esel, D., M. Doganay, and B. Sumerkan. 2003. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Int. J. Antimicrob. Agents 22:70-72.
16. Federal Register. 2002. Department of Health and Human Services, 42 CFR 73, Office of Inspector General, 42 CFR Part 1003. Possession, use, and transfer of select agents and toxins; interim final rule. Fed. Regist. 240: 76886-76905.
17. Friedlander, A. M., S. L. Welkos, M. L. M. Pitt, J. W. Ezzell, P. L. Worsham, B. E. Ivins, J. R. Lowe, G. B. Howe, P. Mikesell, and W. B. Lawrence. 1993. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167:1239-1242.
18. Gold, H. 1955. Anthrax. A report of one hundred seventeen cases. Arch. Intern. Med. 96:387-396.
19. Inglesby, T. V., T. O'Toole, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. M. Friedlander, J. Gerberding, J. Hauer, J. Hughes, J. McDade, M. T. Osterholm, G. Parker, T. M. Perl, P. K. Russell, and K. Tonat. 2002. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287:2236-2252.
20. Jernigan, J. A., D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, and B. A. Perkins. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-944.
21. Jones, M. N., R. J. Beedham, P. C. B. Turnbull, and R. J. Manchee. 1996. Antibiotic prophylaxis for inhalation anthrax. Proceedings of the International Workshop on Anthrax, 19-21 September 1995, Winchester, England. Salisbury Med. Bull. 87(Suppl.):127-128.
22. Kadanali, A., M. A. Tasyaran, and S. Kadanali. 2003. Anthrax during pregnancy: case reports and review. Clin. Infect. Dis. 36:1343-1346.
23. Keim, P., L. B. Price, A. M. Klevytska, K. L. Smith, J. M. Schupp, R. Okinaka, P. J. Jackson, and M. E. Hugh-Jones. 2000. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J. Bacteriol. 182:2928-2936.
24. Kelly, D. J., J. D. Chulay, P. Mikesell, and A. M. Friedlander. 1992. Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys. J. Infect. Dis. 166:1184-1187.
25. Kemmerly, S. A., and G. A. Pankey. 1993. Oral ciprofloxacin therapy for Bacillus cereus wound infection and bacteremia. Clin. Infect. Dis. 16:189.
26. Lightfoot, N. F., R. J. D. Scott, and P. C. B. Turnbull. 1990. Antimicrobial susceptibility of Bacillus anthracis. Proceedings of the International Workshop on Anthrax, 11-13 April 1989, Winchester, England. Salisbury Med. Bull. 68(Suppl.):95-98.
27. Lincoln, R. E., F. Klein, J. S. Walker, B. W. Haines, W. I. Jones, B. G. Mahlandt, and R. H. Friedman. 1964. Successful treatment of rhesus monkeys for septicemic anthrax. Antimicrob. Agents Chemother. 4:759-763.
28. Logan, N. A., and P. C. B. Turnbull. 1999. Bacillus and recently derived genera, p. 357-369. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed., ASM Press, Washington, D.C.
29. Materon, I. C., A. M. Queenan, T. M. Koehler, K. Bush, and T. Palzkill. 2003. Biochemical characterization of β-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob. Agents Chemother. 47:2040-2042.
30. Mohammed, M. J., C. K. Marston, T. Popovic, R. S. Weyant, and F. C. Tenover. 2002. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J. Clin. Microbiol. 40:1902-1907.
31. NCCLS. 2003. Performance standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards, Wayne, Pa.
32. O'Day, D. M., R. S. Smith, C. R. Gregg, P. C. B. Turnbull, W. S. Head, J. A. Ives, and P. C. Ho. 1981. The problem of Bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology 88:833-838.
33. Odendaal, M. W., P. M. Pieterson, V. deVos, and A. D. Botha. 1991. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. Onderstepoort J. Vet. Res. 58:17-19.
34. Patra, G., J. Vaissaire, M. Weber-Levy, C. Le Doujet, and M. Mock. 1998. Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997. J. Clin. Microbiol. 36:3412-3414.
35. Plotkin, S. A., P. S. Brachman, M. Utell, F. H. Bumford, and M. M. Atchison. 1960. An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. Am. J. Med. 29:992-1001.
36. Read, T. D., S. N. Peterson, N. Tourasse, L. W. Baillie, I. T. Paulsen, K. E. Nelson, H. Tettelin, D. E. Fouts, J. A. Eisen, S. R. Gill, E. K. Holtzapple, O. A. Okstad, E. Helgason, J. Rilstone, M. Wu, J. F. Kolonay, M. J. Beanan, R. J. Dodson, L. M. Brinkac, M. Gwinn, R. T. DeBoy, R. Madpu, S. C. Daugherty, A. S. Durkin, D. H. Haft, W. C. Nelson, J. D. Peterson, M. Pop, H. M. Khouri, D. Radune, J. L. Benton, Y. Mahamoud, L. Jiang, I. R. Hance, J. F. Weidman, K. J. Berry, R. D. Plaut, A. M. Wolf, K. L. Watkins, W. C. Nierman, A. Hazen, R. Cline, C. Redmond, J. E. Thwaite, O. White, S. L. Salzberg, B. Thomason, A. M. Friedlander, T. M. Koehler, P. C. Hanna, A. B. Kolsto, and C. M. Fraser. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81-86.
37. Severn, M. 1976. A fatal case of pulmonary anthrax. Br. Med. J. 1:748.
38. Tasyaran, M. S., and S. Erol. 2002. Penicillin therapy for anthrax: a reply to Torres-Tortosa et al. Eur. J. Clin. Microbiol. Infect. Dis. 21:697.
39. Turnbull, P. C. B. 1986. Bacillus cereus toxins, p. 397-448. In F. Dorner and J. Drews (ed.), Pharmacology of bacterial toxins. Pergamon Press, Oxford, United Kingdom.
40. Turnbull, P. C. B., J. E. Bowen, and J. W. Mann. 1996. Stubborn contamination with anthrax spores. Environ. Health 104:171-173.
41. Turnbull, P. C. B., J. M. Hofmeyr, A. M. T. McGetrick, and B. A. Oppenheim. 1986. Isolation of Bacillus anthracis, the agent of anthrax, in the Etosha National Park. A comparison of various media and methods. Madoqua 14:321-331.
42. Turnbull, P. C. B., P. J. Jackson, K. K. Hill, A.-B. Kolsto, P. Keim, and D. J. Beecher. 2002. Longstanding taxonomic enigmas with the 'Bacillus cereus group' are on the verge of being resolved by far-reaching molecular developments. Forecasts on the possible outcome by an ad hoc team, p. 23-36. In R. C. W. Berkeley, M. Heyndrickx, N. A. Logan, and P. de Vos (ed.), Applications and systematics of Bacillus and relatives. Blackwell Science, Oxford, United Kingdom.
43. Weber, D. J., S. M. Saviteer, W. A. Rutala, and C. A. Thomann. 1988. In vitro susceptibility of Bacillus spp. to selected antimicrobial agents. Antimicrob. Agents Chemother. 32:642-645.